Document is current

Any future updates will be listed below

Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes

Crossref DOI link: https://doi.org/10.1186/1741-7015-12-76

Published Online: 2014-05-13

Published Print: 2014-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark